View full meeting coverage »

Eyetube Meeting Coverage:

OIS RETINA 2018

 

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Allegro

  Channels: Retina | Posted 7/23/2018

Vicken Karageozian, MD, President and Chief Medical Officer, Allegro, provides an update on the company’s lead investigational drug, Luminate (ALG-1001), for the treatment of diabetic macular edema (DME) as the company prepares to enter phase 3 clinical trials.

ALG-1001 (Luminate; Allegro)


10 / 11 Series: OIS RETINA 2018